NCYT:LON
Novacyt SA
39,50 GBX
arrow_downward
-0,25%(-0,100) 1 n
okt. 16., 16:35:25 GMT+1 · GBX
search
Minden szimbólum
| Szimbólum | Ár | Változás | Változás %-ban |
|---|
insights_autoLegfontosabb statisztikák generálása a következőhöz: NCYT…
Megnyitás
39,60 GBX
Magas
39,68 GBX
Alacsony
39,20 GBX
Piaci tőkeérték
32,41 M
Átlagos forgalom
102,63 E
Forgalom
12,22 E
52 hetes legmagasabb ár
86,00 GBX
52 hetes legalacsonyabb ár
26,60 GBX
Kinnlevő részvények
37,66 M
Alkalmazottak száma
228
Megnyitás
39,60 GBX
Magas
39,68 GBX
Alacsony
39,20 GBX
Piaci tőkeérték
32,41 M
Átlagos forgalom
102,63 E
Forgalom
12,22 E
52 hetes legmagasabb ár
86,00 GBX
52 hetes legalacsonyabb ár
26,60 GBX
Kinnlevő részvények
37,66 M
Alkalmazottak száma
228
Hírek, történetek
Internetes forrásokból és hírszolgáltató partnerektől
GlobeNewswire
·
50 perccel ezelőtt
OpenWorld (NASDAQ: OPNW) Signs Definitive Merger Agreement to Acquire Blocksight
Business Wire
·
1 órával ezelőtt
Faraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: FFR to Hold Listing Ceremony and First Investor Day at the Nasdaq Tower on Oct. 26; Three New Robotics Product Offerings Launched
marketscreener.com
·
14 perccel ezelőtt
CECO Environmental Corp. Primary Exchange Listing will Change to Texas Stock Exchange from Nasdaq Global Select
Bloomberg.com
·
2 órával ezelőtt
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
Profil
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
Novacyt SA információi